PepEvolutionTesamorelin + Ipamorelin
Tesa/Ipa blend
The FDA-approved GHRH leg paired with Ipamorelin — stronger scientific pedigree than CJC/Ipa, less commonly compounded.
Verdict — C · Emerging / Mixed
A logical upgrade for buyers who want the FDA-validated GHRH leg — stronger evidence pedigree than CJC/Ipa but less available and more expensive. Component-derived evidence only; obtain from a pharmacy with a valid COA for both components.
Overview
The Tesamorelin + Ipamorelin stack pairs the only FDA-approved GHRH analogue (Egrifta) with the selective GHRP Ipamorelin, providing a validated GHRH signal alongside a clean GH-pulse amplifier. The rationale is the same as CJC/Ipa but with a higher-evidence GHRH component. This combination is less commonly compounded than CJC/Ipa and there is no fixed-blend RCT; all evidence is component-derived. Tesamorelin's glucose/IGF-1 implications carry over from the individual compound.
PepScore Breakdown — the four axes
Evidence
35% weightHow strong is the published human science?
Sourcing & COA
30% weightOur moatCan a buyer obtain an independently-verified, high-purity version? — our proprietary layer.
Safety & Risk
25% weightWhat is the real-world harm potential?
Practicality
10% weightHow easy is it to actually run a verified version?
Sources & Citations
Every claim cites a primary source. Citations are machine-audited against NCBI — see methodology.
Educational only — not medical advice. PepScore is an educational research grade, not a prescription or dosing recommendation. Some vendor links are affiliate links — this never affects grades. Consult a licensed healthcare provider before using any compound.